In-house human immunodeficiency virus-1 genotype resistance testing to determine highly active antiretroviral therapy resistance mutations in Hong Kong. Hong Kong Med J, 18: 20-24 (2012).

Publication Latest Publications

Title: In-house human immunodeficiency virus-1 genotype resistance testing to determine highly active antiretroviral therapy resistance mutations in Hong Kong
Authors: Chen JH, Wong KH, Li PC, Chan KK, Lee MP, To SW, Yam WC .
Journal: Hong Kong Med J,18:20-24 (2012)

Journal Impact Factor (I.F.): 0.26
Number of citations (Google Scholar): 1

Abstract

Download: Full text paper

Citation: Chen JH, Wong KH, Li PC, Chan KK, Lee MP, To SW, Yam WC . In-house human immunodeficiency virus-1 genotype resistance testing to determine highly active antiretroviral therapy resistance mutations in Hong Kong Hong Kong Med J,18:20-24 (2012).


Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration
Journal: EBioMedicine (2017)

High Rates of Transmission of Drug-resistant HIV in Aruba Resulting in Reduced Susceptibility to the WHO Recommended First-line Regimen in Nearly Half of Newly Diagnosed HIV-infected Patients
Journal: Clinical Infectious Diseases (2017)

Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis
Journal: Clinical Infectious Diseases (2017)
All publications...


Page design updated by Tulio de Oliveira, 2013